Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/7R8 stock hub

FRA/7R8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/7R8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

285.5M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/7R8FRA/7R8

—

Loading chart…

In the news

Latest news · FRA/7R8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-90.9

P25 n/aP50 n/aP75 n/a

ROIC-47.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/7R8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	479
Employees Change	148%
Employees Change Percent	44.71
Enterprise value	EUR 121.7M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 285.5M
Price	EUR 2.78
Price currency	EUR
Sic	2836
Symbol	fra/7R8
Website	https://www.replimune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-93.92%
EV Earnings	-0.45x
EV/FCF	-0.5x
FCF yield	-84.5%
P/B ratio	1.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -268.2M
Profit Per Employee	EUR -559,834
ROA	-43.24
Roa5y	-20.66
ROCE	-114.4
ROE	-90.88
Roe5y	-38.94
ROIC	-47.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-58.47%
Cagr3y	-43.69%
Cagr5y	-37.42%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 284.1M
Cash	EUR 229.2M
Current Assets	EUR 237.7M
Current Liabilities	EUR 42.5M
Debt	EUR 65M
Debt Equity	EUR 0.36
Debt FCF	EUR -0.27
Equity	EUR 179.3M
Interest Coverage	-40.7
Liabilities	EUR 104.8M
Long Term Assets	EUR 46.4M
Long Term Liabilities	EUR 62.3M
Net Cash	EUR 164.2M
Net Cash By Market Cap	EUR 57.51
Net Cash Growth	-58.13%
Net Debt Equity	EUR -0.92
Tangible Book Value	EUR 179.3M
Tangible Book Value Per Share	EUR 2.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.6
Net Working Capital	EUR -29.6M
Quick ratio	5.43
Working Capital	EUR 196.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-58.45%
200-day SMA	5.62
3Y total return	-82.15%
50-day SMA	4.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.4%
All Time High	42.8
All Time High Change	-93.5%
All Time High Date	2020-12-02
All Time Low	1.43
All Time Low Change	95.09%
All Time Low Date	2026-04-14
ATR	0.35
Ch YTD	-66.25
High	2.78
High52	11.6
High52 Date	2025-07-22
High52ch	-76%
Low	2.78
Low52	1.43
Low52 Date	2026-04-14
Low52ch	95.1%
Ma50ch	-40.15%
Price vs 200-day SMA	-50.45%
RSI	45.05
RSI Monthly	36.92
RSI Weekly	36.63
Sharpe ratio	0.76x
Sortino ratio	1.22
Total Return	-22.99%
Tr YTD	-66.25
Tr1m	-59.56%
Tr1w	29.79%
Tr3m	-54.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -276.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,901,579%
Net Borrowing	-594,421.4
Shares Insiders	1.8%
Shares Institutions	66.76%
Shares Qo Q	0.3%
Shares Yo Y	22.99%
Short Ratio	3.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -268.9M
Average Volume	1,192.5x
Bv Per Share	2.25
CAPEX	EUR -4.6M
Ch1m	-59.56
Ch1w	29.79
Ch1y	-58.45
Ch3m	-54.36
Ch3y	-82.15
Ch5y	-90.4
Ch6m	-59.36
Change	-3.77%
Change From Open	0.07
Close	2.89
Days Gap	-3.84
Depreciation Amortization	4,527,269.1
Earnings Date	2026-05-15
EBIT	EUR -276.1M
EBITDA	EUR -271.6M
EPS	EUR -2.93
F Score	1
FCF	EUR -241.3M
FCF EV Yield	-198.19x
Financing CF	8,930,075
Fiscal Year End	March
Founded	2,015
Income Tax	EUR -356,011
Investing CF	184,509,733
Is Primary Listing	0
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Ma150	6.06
Ma150ch	-54.06%
Ma20	2.24
Ma20ch	24.17%
Net CF	-41,980,293
Next Earnings Date	2026-05-15
Open	2.78
Position In Range	100
Ppne	42,679,623.4
Price Date	2026-05-08
Ptbv Ratio	1.59
Relative Volume	0.16x
Share Based Comp	27,618,076
Tr6m	-59.36%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/7R8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7R8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/7R8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.8%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/7R8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.0

Neutral momentum band

Price vs 200-day MA

-50.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/7R8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7R8 stock rating?

fra/7R8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7R8 analysis?

The full report lives at /stocks/fra/7R8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7R8?

The latest report frames fra/7R8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7R8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.